Lyso-Gb3 modulates the gut microbiota and decreases butyrate production
Open Access
- 19 August 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Abstract
Fabry disease is a rare X-linked lysosomal storage disorder resulting from deficient activity of α-galactosidase A, leading to the accumulation of glycosphingolipids such as globotriaosylsphingosine (lyso-Gb3). The gastrointestinal symptoms of this disease may be disabling, and the life expectancy of affected patients is shortened by kidney and heart disease. Our hypothesis was that lyso-Gb3 may modify the gut microbiota. The impact of a clinically relevant concentration of lyso-Gb3 on mono- or multispecies bacterial biofilms were evaluated. A complex bacterial community from the simulated transverse colon microbiota was studied using quantitative PCR to estimate different bacterial group concentrations and a HPLC was used to estimate short-chain fatty acids concentrations. We found that lyso-Gb3 increased the biofilm-forming capacity of several individual bacteria, including Bacteroides fragilis and significantly increased the growth of B. fragilis in a multispecies biofilm. Lyso-Gb3 also modified the bacterial composition of the human colon microbiota suspension, increasing bacterial counts of B. fragilis, among others. Finally, lyso-Gb3 modified the formation of short-chain fatty acids, leading to a striking decrease in butyrate concentration. Lyso-Gb3 modifies the biology of gut bacteria, favoring the production of biofilms and altering the composition and short-chain fatty-acid profile of the gut microbiota.Keywords
Funding Information
- Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI16/02057, PI18/01366, RD016/0009)
- Comunidad de Madrid (B2017/BMD-3686)
This publication has 85 references indexed in Scilit:
- Fibrosis: a key feature of Fabry disease with potential therapeutic implicationsOrphanet Journal of Rare Diseases, 2013
- Bacterial Diversity in Meconium of Preterm Neonates and Evolution of Their Fecal Microbiota during the First Month of LifePLOS ONE, 2013
- Biofilm-growing intestinal anaerobic bacteriaFEMS Immunology & Medical Microbiology, 2012
- Fabry diseaseOrphanet Journal of Rare Diseases, 2010
- A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responsesNature Medicine, 2009
- EnterotoxigenicBacteroides fragilis: a Rogue among SymbiotesClinical Microbiology Reviews, 2009
- Application of a high throughput Alamar blue biofilm susceptibility assay to Staphylococcus aureus biofilmsAnnals of Clinical Microbiology and Antimicrobials, 2009
- Elevated globotriaosylsphingosine is a hallmark of Fabry diseaseProceedings of the National Academy of Sciences, 2008
- Evaluation of Quantitative Analysis of Cultures from Sonicated Retrieved Orthopedic Implants in Diagnosis of Orthopedic InfectionJournal of Clinical Microbiology, 2008
- Composition and Metabolic Activities of Bacterial Biofilms Colonizing Food Residues in the Human GutApplied and Environmental Microbiology, 2006